UNSPSC 51183110: Ingliforib

This classification denotes an anti-diabetic agent with the molecular formula C23H24ClN3O5, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) UII7156WLU, chemically known as 1h-indole-2-carboxamide, 5-chloro-n-((1s,2r)-3-((3r,4s)-3,4-dihydroxy-1-pyrrolidinyl)-2-hydroxy-3-oxo-1-(phenylmethyl)propyl)- but more generally known as ingliforib, which bears US NIH Compound Identifier 6451325.

UNSPSC 51183110 Ingliforib is a Commodity code covering pharmaceutical products that state and local governments procure through cooperative purchasing arrangements for distribution across public facilities. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration's Office of State Procurement, solicited generic multi-source pharmaceuticals and over-the-counter products in early 2026, targeting manufacturers who can supply comprehensive product catalogs with specified National Drug Codes and packaging configurations through authorized wholesale distribution channels. Vendors must meet FDA compliance, maintain current Good Manufacturing Practices (cGMP) certification, and comply with the Drug Supply Chain Security Act (DSCSA). The scope requires contractual relationships with at least two of three authorized wholesalers (AmerisourceBergen Drug Corporation/Cencora, Cardinal Health 110 and 112, and Morris & Dickson Co., LLC) and chargeback system capability. Insurance requirements include $5,000,000 commercial general liability, $2,000,000 network security and privacy liability, and $2,000,000 professional liability per occurrence. Participation spans multiple states, with Oregon specifically named alongside Minnesota as a participating jurisdiction in the cooperative vehicle.

MMCAP issued the RFP for generic multi-source pharmaceuticals and OTC products on January 20, 2026, with proposals due March 26, 2026. Evaluation weighted price competitiveness at 75 percent, with secondary criteria covering fixed pricing (10 percent), administrative compliance (5 percent), EDI capability (5 percent), and agreement to a 3 percent administrative fee (5 percent). Awards are slated to be communicated to authorized wholesalers by May 15, 2026, with contracts effective July 1, 2026 for two years, subject to MMCAP's optional extensions. No specific dollar values or set-aside designations were disclosed in the documentation. Vendors face performance penalties ranging from $200 to $1,500 per violation for issues such as late reporting, missed onboarding timelines, or improper class-of-trade denials.